Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents

Reshma Mahtani; Nina Oestreicher; Deepa Lalla; Augustina Ogbonnaya; Vishal Saundankar; Joanne M. Willey; Anna D. Coutinho; Kelly McCann

Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents

Reshma Mahtani, Nina Oestreicher, Deepa Lalla, Augustina Ogbonnaya, Vishal Saundankar, Joanne M. Willey, Anna D. Coutinho, Kelly McCann

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Clinical Breast Cancer
State	Published - 2021

Disciplines

Medicine and Health Sciences

Cite this

@article{a6bf5070a2844f52a1d147ade3e8a23c,

title = "Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents",

author = "Reshma Mahtani and Nina Oestreicher and Deepa Lalla and Augustina Ogbonnaya and Vishal Saundankar and Willey, {Joanne M.} and Coutinho, {Anna D.} and Kelly McCann",

note = "1 Baptist Health South Florida, Plantation, Florida, United States. Electronic address: [email protected]. 2 Puma Biotechnology, Inc., University of California, Department of Clinical Pharmacy, San Francisco, CA. 3 Puma Biotechnology, Inc., Los Angeles, CA. 4 Xcenda, LLC, Carrollton, TX. 5 University of California, Los Angeles, Los Angeles, CA.",

year = "2021",

language = "American English",

journal = "Clinical Breast Cancer",

}

TY - JOUR

T1 - Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents

AU - Mahtani, Reshma

AU - Oestreicher, Nina

AU - Lalla, Deepa

AU - Ogbonnaya, Augustina

AU - Saundankar, Vishal

AU - Willey, Joanne M.

AU - Coutinho, Anna D.

AU - McCann, Kelly

N1 - 1 Baptist Health South Florida, Plantation, Florida, United States. Electronic address: [email protected]. 2 Puma Biotechnology, Inc., University of California, Department of Clinical Pharmacy, San Francisco, CA. 3 Puma Biotechnology, Inc., Los Angeles, CA. 4 Xcenda, LLC, Carrollton, TX. 5 University of California, Los Angeles, Los Angeles, CA.

PY - 2021

Y1 - 2021

UR - https://pubmed.ncbi.nlm.nih.gov/35067467/

M3 - Article

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

ER -

Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents

Disciplines

Other files and links

Cite this